The public health practice of adding fluoride to drinking water is facing heavy scrutiny from the Trump administration, and ...

Colgate-Palmolive posted a higher profit in the first quarter but lowered 2025 earnings guidance due to tariffs.

Calling all income investors! Two dividend kinds deserve your attention in 2025: Colgate-Palmolive (NYSE:CL) and Emerson ...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Colgate-Palmolive fair value estimate is US$135 Current ...

We look at Colgate-Palmolive Company's Q1 results, market challenges, and tariff impacts. Read to see if the CL stock is ...

Colgate-Palmolive on Friday reported better-than-expected first-quarter results and lifted its full-year sales outlook, ...

JP Morgan analyst Andrea Teixeira maintained Colgate-Palmolive with an Overweight rating and raised the price target from $95 ...

Organic sales rose 1.4% during the quarter, with pricing up 1.5% and volume down 0.1%. The impact of FX was a negative 4.4% ...

The owner of skin care brand Sanex is also expecting a price hike on sold goods as a result of US President Donald Trump’s ...

Paxton is accusing the companies that sell Colgate and Crest fluoride toothpaste of illegally marketing their products to ...

Colgate-Palmolive surpassed earnings expectations in Q1 2025, despite experiencing a decline in overall sales.

(Richard B. Levine/Zuma Press) Colgate-Palmolive said consumers have been buying less toothpaste and soap as they brace for economic uncertainty, leading the company to cut its annual earnings ...